Shock Wave Therapy for Management of Spasticity in Patients With Cerebral Palsy
Cerebral Palsy, Spasticity, Muscle, Extracorporeal Shock Wave Therapy
About this trial
This is an interventional treatment trial for Cerebral Palsy
Eligibility Criteria
Inclusion Criteria: Patients with CP. With a CP classified as spastic. Spasticity in the Triceps Surae muscle. Who have a Gross Motor Classification (GMFCS) level between l and ll Having signed the informed consent by the participant or your legal guardian Exclusion Criteria: Have received treatment with shock waves in the Triceps Surae or any other muscle of the lower extremity in the 6 months before the study. Have received treatment with botulinum toxin and/or treatment focal intramuscular injection with phenol or alcohol in the Triceps Surae or some other lower extremity muscle in the 6 months before the study. Patients who have undergone surgery for deformities foot orthotics in the last year. Fixed deformities in the ankle joint. Clinical signs of myopathy and neuropathy. Infection or tumor at the site of application of the therapy*. Severe blood dyscrasia*. Blood coagulation disorders*. Treatment with oral anticoagulants* Contraindications of radial extracorporeal shock wave therapy.
Sites / Locations
- Fundació Aspace Catalunya
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Control Group
Experimental Group A
Experimental Group B
3 rESWT sessions with a time interval of 1 week between each session.
3 rESTW sessions with a time interval of 2 weeks between each session.
3 rESTW sessions with a time interval of 4 weeks between each session.